ADAPTIVE BIOTECHNOLOGIES CORPORATION
NPI 1508105024
Clinical Medical Laboratory in Seattle, WA

Active since February 04, 2013CLIA 50D2046518 · Accreditation
1165 EASTLAKE AVE E, SEATTLE, WA 98109(888) 552-8988(206) 299-0488 Get Directions Write a Review

NPPES record last updated: March 31, 2025. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Record update history: Mar 31, 2025, Mar 18, 2025, Aug 10, 2023 and 3 more (6 updates tracked since 2018).

About Adaptive Biotechnologies Corporation NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

ADAPTIVE BIOTECHNOLOGIES CORPORATION (NPI 1508105024) is a healthcare organization registered as a clinical medical laboratory in Seattle, Washington and active in the NPI registry since February 2013. The organization holds an CLIA Accreditation certificate valid through April 4, 2028 and lists Chad Robins, Ceo, President, Co-founder, as its authorized official.

NPPES Registry Identity

NPI1508105024
Entity TypeOrganization
Primary Taxonomy291U00000X
Legal Business NameADAPTIVE BIOTECHNOLOGIES CORPORATION
Location Address1165 EASTLAKE AVE ESeattle, WA 98109-4456
Mailing Address1165 Eastlake Ave ESeattle, WA 98109-4456 · (888) 552-8988 · Fax (866) 623-4408
Fax(206) 299-0488
Organization SubpartNo
Authorized OfficialChad RobinsCeo, President, Co-founder · (888) 552-8988
Enumeration DateFebruary 4, 2013
Last NPPES UpdateMarch 31, 20256 updates tracked since enumeration
NPPES CertifiedMarch 31, 2025
NPI 1508105024 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyClinical Medical LaboratoryLaboratories
Taxonomy Code291U00000X
License Licensed in WA · 50D2046518
Definition
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
1165 EASTLAKE AVE E, Seattle, WA 98109

Accepted Insurance

CLIA Laboratory Certificates CMS CLIA

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Accreditation 50D2046518

Adaptive Biotechnologies · Seattle, WA
Active · expires Apr 4, 2028
CLIA Number50D2046518
Laboratory TypeIndependent
Certificate Effective DateMarch 2, 2015
Certificate Expiration DateApril 4, 2028
Laboratory DirectorDr. Jarrod W. Heck
Laboratory Phone(855) 466-8667
Laboratory LocationAdaptive Biotechnologies1165 Eastlake Ave E, Seattle, WA 98109
CLIA data matches this NPI record on: Address Name
This is a certificate that is issued to a laboratory on the basis of the laboratory's accreditation by an accreditation organization approved by CMS.

Areas of Expertise CMS Part B claims

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Molecular pathology procedure 81479
A molecular pathology procedure is a specialized lab test that analyzes your genes at a molecular level. It helps identify genetic variations or changes that may affect your health. This information can assist in diagnosing, monitoring, and deciding treatment for certain conditions.
5,123 services5,118 patients

Other Providers at the Same Location NPPES 2

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Pathology (Clinical Laboratory Director, Non-physician)
1165 EASTLAKE AVE E
SEATTLE, WA 98109
Pathology (Molecular Genetic Pathology)
1165 EASTLAKE AVE E
SEATTLE, WA 98109

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Adaptive Biotechnologies Corporation's NPI number?

The NPI number for Adaptive Biotechnologies Corporation is 1508105024. It was assigned to this organization in the NPPES registry on February 4, 2013.

Where is Adaptive Biotechnologies Corporation located?

Adaptive Biotechnologies Corporation is located at 1165 Eastlake Ave E, Seattle, WA 98109. The listed phone number is (888) 552-8988.

What is Adaptive Biotechnologies Corporation's specialty?

The primary specialty registered for this NPI is Clinical Medical Laboratory with taxonomy code 291U00000X.

Does Adaptive Biotechnologies Corporation hold a CLIA laboratory certificate?

Yes. A Certificate of Accreditation (number 50D2046518) is associated with this NPI, valid through April 4, 2028. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.

What insurance does Adaptive Biotechnologies Corporation accept?

Health plans from Blue Care Network of Michigan, Blue Cross Blue Shield of Michigan Mutual Insurance Company, Blue Cross and Blue Shield of Alabama, Blue Cross and Blue Shield of Louisiana and Blue Cross and Blue Shield of Texas and 9 other insurers list Adaptive Biotechnologies Corporation as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Adaptive Biotechnologies Corporation was last updated on March 31, 2025. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 16 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.